Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in Leishmania infantum
Summary: Antileishmanial chemotherapy is currently limited due to severe toxic side effects and drug resistance. Hence, new antileishmanial compounds based on alternative approaches, mainly to avoid the emergence of drug resistance, are needed. The present work aims to decipher the mechanism of acti...
Hoofdauteurs: | Sameh Obeid, Eloisa Berbel-Manaia, Valérie Nicolas, Indira Dennemont, Julien Barbier, Jean-Christophe Cintrat, Daniel Gillet, Philippe M. Loiseau, Sébastien Pomel |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Elsevier
2023-11-01
|
Reeks: | iScience |
Onderwerpen: | |
Online toegang: | http://www.sciencedirect.com/science/article/pii/S2589004223022216 |
Gelijkaardige items
-
Antileishmanial activity of terpenylquinones on Leishmania infantum and their effects on Leishmania topoisomerase IB
door: Yolanda Pérez-Pertejo, et al.
Gepubliceerd in: (2019-12-01) -
Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy
door: M. Carmen Guillén, et al.
Gepubliceerd in: (2020-05-01) -
Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival
door: Kendi Okuda, et al.
Gepubliceerd in: (2022-09-01) -
Antileishmanial Activity of BNIPDaoct- and BNIPDanon-loaded Emulsomes on Leishmania infantum Parasites
door: Zeynep Islek, et al.
Gepubliceerd in: (2022-01-01) -
The different impact of drug-resistant Leishmania on the transcription programs activated in neutrophils
door: Míriam Díaz-Varela, et al.
Gepubliceerd in: (2024-05-01)